Book Review: Guidelines for Preclinical Evaluation and Clinical Trials in Osteoporosis

Abstract

Get full access to this article

View all access options for this article.

References

Guidelines for preclinical and clinical evaluation of agents used in the prevention and treatment of postmenopausal osteoporosis. Rockville, MD: Division of Metabolism and Endocrine Drug Products, the Food and Drug Administration, 1994.

Reginster

Compston

Jones

Kaufman

Audran

Bou-Venot

Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosis (editorial). Calcif Tissue Int 1995;57:247–50.